Conclusion
An immunodominant gliadin epitope provoking celiac disease seems to be notably resistant to digestion with pepsin and pancreatic endopeptidases. This means that the capacity of the intestinal mucosa to digest it will be critical to the disease provoking capability of the peptide. We have shown that a peptide containing the immunodominant epitope is efficiently digested from the N-terminal end by dipeptidyl peptidase IV. Similar results have been obtained in a parallel work by Hausch et al.12, who in addition demonstrated that dipeptidyl carboxypeptidase I is of importance for digestion of the epitope from the C-terminal end. We have earlier demonstrated that dipeptidyl peptidase IV is low in celiac disease and also that it shows a substantial depression in patients in remission13. Even if a variation of the enzyme level is not of primary importance in the pathogenesis of the disease, it may that the relative capacity for the digestion of the peptide can be exceeded after a meal rich in wheat proteins, and thereby contribute to the development of the disease.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Best Poster Award, International Conference on Dipeptidyl Aminopeptidases, Berlin, September 2002
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Marsh, M. N., 1992, Gluten, Major Histocompatibility Complex, and the Small Intestine. A Molecular and Immunobiologic Approach to the Spectrum of Gluten Sensitivity (‘Celiac Sprue’). Gastroenterology, 102: 330–354.
Sollid, L. M., 2000, Molecular Basis of Celiac Disease. Annu. Rev. Immunol, 18: 53–81.
Lundin, K. E.; Scott, H.; Hansen, T.; Paulsen, G. Halstensen, T. S.; Fausa, O.; Thorsby, E.; Sollid, L. M., 1993, Gliadin-Specific, HLA-DQ(Alpha l*0501, Beta 1*0201) Restricted T Cells Isolated From the Small Intestinal Mucosa of Celiac Disease Patients. J Exp. Med, 178: 187–196.
Anderson, R. P.; Degano, P.; Godkin, A. J.; Jewell, D. P.; Hill, A. V., 2000, In Vivo Antigen Challenge in Celiac Disease Identifies a Single Transglutaminase-Modified Peptide As the Dominant A-Gliadin T-Cell Epitope. Nat. Med, 6: 337–342.
Arentz-Hansen, H.; Korner, R.; Molberg, O.; Quarsten, H.; Vader, W.; Kooy, Y. M.; Lundin, K. E.; Koning, F.; Roepstorff, P.; Sollid, L. M.; McAdam, S. N., 2000, The Intestinal T Cell Response to Alpha-Gliadin in Adult Celiac Disease Is Focused on a Single Deamidated Glutamine Targeted by Tissue Transglutaminase. J Exp. Med, 191: 603–612.
Sjöström, H.; Lundin, K. E.; Molberg, O.; Korner, R.; McAdam, S. N.; Anthonsen, D.; Quarsten, H.; Norén, O.; Roepstorff, P.; Thorsby, E.; Sollid, L. M., 1998, Identification of a Gliadin T-Cell Epitope in Coeliac Disease: General Importance of Gliadin Deamidation for Intestinal T-Cell Recognition. Scand J Immunol, 48: 111–115.
Piper, J. L.; Gray, G. M.; Khosla, C., 2002, High Selectivity of Human Tissue Transglutaminase for Immunoactive Gliadin Peptides: Implications for Celiac Sprue. Biochemistry, 41: 386–393.
Dieterich, W.; Ehnis, T.; Bauer, M.; Donner, P.; Volta, U.; Riecken, E. O.; Schuppan, D., 1997, Identification of Tissue Transglutaminase As the Autoantigen of Celiac Disease. Nat. Med, 3: 797–801.
Schuppan, D.; Dieterich, W.; Riecken, E. O., 1998, Exposing Gliadin As a Tasty Food for Lymphocytes. Nat. Med, 4: 666–667.
Kessler, M.; Acuto, O.; Storelli, C.; Murer, H.; Muller, M.; Semenza, G., 1978, A Modified Procedure for the Rapid Preparation of Efficiently Transporting Vesicles From Small Intestinal Brush Border Membranes. Their Use in Investigating Some Properties of D-Glucose and Choline Transport Systems. Biochim. Biophys. Acta, 506: 136–154.
Sjöström, H., 2001, Deamidation of gliadin peptides in the pathogenesis of celiac disease. In: Proocedings of the Workshop on Transglutaminases, Protein Cross-Linking and Coeliac Disease. (Mäki M, Tossavainen M. eds.) University Press, Tampere, Finland, pp. 117–122.
Hausch, F.; Shan, L.; Santiago, N. A.; Gray, G. M.; Khosla, C., 2002, Intestinal Digestive Resistance of Immunodominant Gliadin Peptides. Am. J Physiol Gastrointest. Liver Physiol, 283: G996–G1003.
Sjöström, H.; Norén, O.; Krasilnikoff, P. A.; Gudmand-Hoyer, E., 1981, Intestinal Peptidases and Sucrase in Coeliac Disease. Clin. Chim. Acta, 109: 53–58.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this chapter
Cite this chapter
Koch, S., Anthonsen, D., Skovbjerg, H., Sjöström, H. (2004). On the Role of Dipeptidyl Peptidase IV in the Digestion of an Immunodominant Epitope in Celiac Disease. In: Back, N., Cohen, I.R., Kritchevsky, D., Lajtha, A., Paoletti, R. (eds) Dipeptidyl Aminopeptidases in Health and Disease. Advances in Experimental Medicine and Biology, vol 524. Springer, Boston, MA. https://doi.org/10.1007/0-306-47920-6_22
Download citation
DOI: https://doi.org/10.1007/0-306-47920-6_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47717-1
Online ISBN: 978-0-306-47920-5
eBook Packages: Springer Book Archive